Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of patients with rheumatoid arthritis and age‐stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan
Ayako Nakajima, Ryoko Sakai, Eisuke Inoue, et al.
International Journal of Rheumatic Diseases (2020) Vol. 23, Iss. 12, pp. 1676-1684
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments
Kazuhiro Maeda, Ken Yoshida, Tetsuro Nishizawa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2871-2871
Open Access | Times Cited: 83
Literature Review of Studies Using the National Database of the Health Insurance Claims of Japan (NDB): Limitations and Strategies in Using the NDB for Research
Maiko Suto, Arisa Iba, Takehiro Sugiyama, et al.
JMA Journal (2024) Vol. 7, Iss. 1, pp. 10-20
Open Access | Times Cited: 10
Consensus statement on the management of late-onset rheumatoid arthritis
Masayo Kojima, Takahiko Sugihara, Yutaka Kawahito, et al.
Modern Rheumatology (2024) Vol. 34, Iss. 6, pp. 1095-1102
Closed Access | Times Cited: 6
Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis
Naonobu Sugiyama, Frances Terry, Andres H. Gutiérrez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Treatment strategies for elderly-onset rheumatoid arthritis in the new era
Takahiko Sugihara
Modern Rheumatology (2021) Vol. 32, Iss. 3, pp. 493-499
Closed Access | Times Cited: 28
Prevalence, comorbidities, and disease-related complications of rheumatoid arthritis in Colombia: a national cross-sectional study based on administrative claims data
Kevin Maldonado-Cañón, Giancarlo Buitrago, Gerardo Quintana-López
Advances in Rheumatology (2025) Vol. 65, Iss. 1
Open Access
Antiretroviral therapies and status of people living with HIV in Japan: An update from hospital survey and national database
Yoshiyuki Yokomaku, Tatsuya Noda, Mayumi Imahashi, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317655-e0317655
Open Access
Osteoporosis and Rheumatoid Arthritis: Mechanisms Underlying Osteoclast Differentiation and Activation or Factors Associated with Hip Fractures
Takeshi Miyamoto
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1138-1138
Open Access
Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX
John А. Kanis, Helena Johansson, Eugène McCloskey, et al.
Osteoporosis International (2025)
Closed Access
Management of Late-Onset Rheumatoid Arthritis with Treat-to-Target Strategy
Masayoshi Harigai, Takahiko Sugihara
Drugs & Aging (2025)
Closed Access
Synovial macrophages drive severe joint destruction in established rheumatoid arthritis
Dengfeng Wu, Yiping Huang, Jun Zhao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry
Koshiro Sonomoto, Shingo Nakayamada, Hiroaki Tanaka, et al.
Rheumatology and Therapy (2025)
Open Access
Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance
Michiaki Takagi, Tatsuya Atsumi, Hiroaki Matsuno, et al.
Modern Rheumatology (2022) Vol. 33, Iss. 4, pp. 647-656
Closed Access | Times Cited: 17
Risk factors of acromial and scapular spine stress fractures differ by indication: a study by the ASES Complications of Reverse Shoulder Arthroplasty Multicenter Research Group
Ryan Lohre, Daniel P. Swanson, Kuhan A. Mahendraraj, et al.
Journal of Shoulder and Elbow Surgery (2023) Vol. 32, Iss. 12, pp. 2483-2492
Closed Access | Times Cited: 10
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis
Takahiko Sugihara, Yutaka Kawahito, Yuko Kaneko, et al.
Modern Rheumatology (2024) Vol. 34, Iss. 5, pp. 867-880
Open Access | Times Cited: 3
Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J)
Shuji Asai, Mochihito Suzuki, Ryota Hara, et al.
Modern Rheumatology (2024) Vol. 34, Iss. 5, pp. 892-899
Closed Access | Times Cited: 3
The Association Between Deep Vein Thrombosis, Pulmonary Embolism, and Janus Kinase Inhibitors: Reporting Status and Signal Detection in the Japanese Adverse Drug Event Report Database
Tae Maeshima, Sayaka Aisu, Naoki Ohkura, et al.
Drugs - Real World Outcomes (2024) Vol. 11, Iss. 3, pp. 369-375
Open Access | Times Cited: 3
Indigenous Nigeria medicinal herbal remedies: A potential source for therapeutic against rheumatoid arthritis
Uche O. Arunsi, Chioma E. Ogbuka, Paschal Etusim, et al.
Experimental Biology and Medicine (2022) Vol. 247, Iss. 13, pp. 1148-1178
Open Access | Times Cited: 15
Unincreased risk of hospitalized infection under targeted therapies versus methotrexate in elderly patients with rheumatoid arthritis: a retrospective cohort study
Ryoko Sakai, Eiichi Tanaka, Masako Majima, et al.
Arthritis Research & Therapy (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 13
A preliminary survey of rheumatologists on the management of late-onset rheumatoid arthritis in Japan
Satoshi Takanashi, Yuko Kaneko, Yutaka Kawahito, et al.
Internal Medicine (2024) Vol. 63, Iss. 24, pp. 3299-3306
Open Access | Times Cited: 2
Inflammatory diseases causing joint and bone destruction: rheumatoid arthritis and hemophilic arthropathy
Asuka Terashima, Kumiko Ono, Yasunori Omata, et al.
Journal of Bone and Mineral Metabolism (2024)
Open Access | Times Cited: 2
Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case post-marketing surveillance study
Nami Okamoto, Tatsuya Atsumi, Michiaki Takagi, et al.
Modern Rheumatology (2024)
Closed Access | Times Cited: 2
Circulating DNA methylation level of CXCR5 correlates with inflammation in patients with rheumatoid arthritis
Yiming Shi, Cen Chang, Lingxia Xu, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 6
Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis
Wataru Hirose, Masayoshi Harigai, Koichi Amano, et al.
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study
Katsuhiko Takabayashi, Fumihiko Ando, Kei Ikeda, et al.
Modern Rheumatology (2021) Vol. 32, Iss. 5, pp. 857-865
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top